| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Atara Biotherapeutics, Inc. (ATRA) has 3 insiders with recent SEC Form 4 filings, including 0 buys and 35 sells. ATRA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 1.32M | $14.26M | - | |
| CEO | 143.1K | $1.54M | - | |
| Other | 52.0K | $560.6K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 28, 2015 | Ciechanover Isaac E. | Chief Executive Officer | Sell | 5,200 | $39.25 | $204,086.00 | -0.3% | |
| Aug 24, 2015 | Gallagher Carol Giltner | Director | Sell | 17,622 | $42.34 | $746,090.26 | -1.9% | |
| Aug 19, 2015 | Gallagher Carol Giltner | Director | Sale+OE | 11,639 | $48.78 | $567,708.82 | -3.3% | |
| Aug 18, 2015 | McGrath John | Chief Financial Officer | Sale+OE | 6,000 | $49.38 | $296,280.00 | -15.9% | |
| Aug 18, 2015 | Soffer Gad | Chief Operating Officer | Sale+OE | 16,489 | $49.76 | $820,525.90 | -7.3% | |
| Aug 17, 2015 | Clark Mitchall G. | Chief R &Qa Officer | Sale+OE | 7,829 | $46.19 | $361,621.51 | -18.7% | |
| Aug 17, 2015 | Haqq Christopher | Chief Medical Officer | Sale+OE | 1,604 | $45.91 | $73,632.00 | -0.3% | |
| Jul 31, 2015 | Haqq Christopher | Chief Medical Officer | Sell | 2,500 | $55.43 | $138,575.00 | -1.0% | |
| Jul 31, 2015 | Ciechanover Isaac E. | Chief Executive Officer | Sell | 5,200 | $56.18 | $292,160.00 | -0.3% | |
| Jul 17, 2015 | Ciechanover Isaac E. | Chief Executive Officer | Sell | 5,200 | $60.71 | $315,680.00 | -0.3% |